Biotech Strategy Blog

I am excited to be attending, for the first time, the Biotechnology Industry Organization (BIO) international convention that takes place in Washington DC in just over a week’s time from Monday June 27 to Thursday, June 30^th.

This meeting has something for everyone interested in the biotechnology industry whether it be deal making, partnering, licensing, drug discovery or personalized medicine. There are 16 specialized tracks where industry experts provide insight and best practices.

In addition, there are numerous networking and social events plus an exhibit hall that showcases the world’s biotech regions and how they are promoting innovation.

At meetings where there are parallel sessions, I apply “the law of two feet” (thanks to Podcamp for this) that says if you are not getting what you want from the session, it’s OK to walk out and go to another one.

My top 10 sessions at BIO reflect my personal interests in innovation, science and new product development:

Tuesday June 28

• How will we afford Personalized Medicines?
• The Biomarkers Consortium: Facilitating the Development and Qualification of Biological Markers
• Personalized Oncology: The emergence of Personalized Medicine Strategies in Oncology Clinical Development and Deal Making
• Navigating the New Law on Licensing Biosimilars

Wednesday June 29

• Lessons from a Mature Public-Private Partnership. The Alzheimer’s Disease Neuroimaging Initiative
• Emerging Markets. The Future of Growth for Biologics?
• The Role of Imaging Biomarkers in Early Phase CNS Drug Development
• The Promise of MicroRNA-based Therapeutics in Cancer

Thursday Jun 30

• After the Fall. Venture Capital and the Biotech Funding Landscape
• Regulatory Issues for Tissue Engineered Products

If you have plans to be at BIO 2011 do say hello after one of the sessions or receptions. You can reach me at the meeting via twitter (@3NT).  See you in DC!

Posted by Pieter Droppert